Rigel Pharmaceuticals
RIGL
$1.10
Share price
0.00%
Change (1 day)
-1.79%
Change (1 year)
Categories
P/S ratio for Rigel Pharmaceuticals (RIGL)
P/S ratio as of April 2024 (TTM): 1.65
According to Rigel Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.65077. At the end of 2023 the company had a P/S ratio of 2.16.
P/S ratio history for Rigel Pharmaceuticals from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 2.16 | 0.33% |
| 2022 | 2.16 | -29% |
| 2021 | 3.04 | -44.23% |
| 2020 | 5.44 | -10.2% |
| 2019 | 6.06 | -29.81% |
| 2018 | 8.64 | -93.19% |
| 2017 | 127 | 997.26% |
| 2016 | 11.6 | 21.66% |
| 2015 | 9.50 | -60.8% |
| 2014 | 24.2 | -30.56% |
| 2013 | 34.9 | -86.14% |
| 2012 | 252 | 112.73% |
| 2011 | 118 | 3658.21% |
| 2010 | 3.15 | -99.52% |
| 2009 | 659 | |
| 2007 | 50.7 | 467.34% |
| 2006 | 8.93 | -28.87% |
| 2005 | 12.6 | -87.63% |
| 2004 | 101 | 293.89% |
| 2003 | 25.8 | 708.06% |
| 2002 | 3.19 | -72.2% |
| 2001 | 11.5 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 5.14 | 211.19% | 🇺🇸 USA |
 AstraZeneca AZN | 5.09 | 208.19% | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | 0.6130 | -62.87% | 🇺🇸 USA |
 ChemoCentryx CCXI | 101 | 5,988.92% | 🇺🇸 USA |